Featured Opening Session Speakers
The 31st Conference on Retroviruses and Opportunistic Infections (CROI), held from March 3 to 6, 2024, is planned as an in-person conference at the Colorado Convention Center in Denver, Colorado. The best and most consequential original research on HIV and related conditions will define the science at the conference. CROI 2024 will also accept important new findings on SARS-CoV-2 and the mpox virus. The in-person conference will also feature innovative interactive sessions, rich poster sessions, and networking opportunities.
The CROI 2024 Program below is preliminary and subject to change. New information will be posted as it becomes available.
8:30 AM MT - 12:30 PM MT
New Investigator Workshop
Scott M. Hammer Workshop for New Investigators and Trainees
Widely considered the most informative and comprehensive session, this workshop highlights key presentations that will take place during CROI. Although the workshop is directed toward new investigators and trainees (eg, undergraduate students, graduate students, postdoctoral fellows, and physician fellows), all CROI attendees are encouraged to attend. Scholarship recipients are required to attend.
Moderators: Katharine J. Bar, Hospital of the University of Pennsylvania (Philadelphia, PA, USA), and Serena S. Spudich, Yale University (New Haven, CT, USA)
-
- Community Perspective on CROI 2024
Adam Castillejo, London Patient (London, United Kingdom) - Navigating Presentations in Molecular Virology at CROI 2024
Frank Kirchhoff, Ulm University Medical Center (Ulm, Germany) - Navigating Presentations in SARS-CoV-2 and HIV Immunology
Elizabeth Connick, University of Arizona (Tucson, AZ, USA) - Navigating Presentations in HIV Cure at CROI 2024
Afam A. Okoye, Oregon Health and Sciences University (Portland, OR, USA) - Navigating Presentations in Prevention at CROI 2024
LaRon Nelson, Yale University (New Haven, CT, USA) - Navigating Presentations in Pediatric HIV at CROI 2024
Jennifer Jao, Northwestern University (Chicago, IL, USA) - Special Presentation by the Director of the NIAID
Jeanne Marrazzo, National Institute of Allergy and Infectious Diseases (Bethesda, MD, USA)
- Community Perspective on CROI 2024
2:00 PM PT - 4:00 PM MT
CONCURRENT TECHNICAL WORKSHOPS
Frontiers in Laboratory Technologies
Moderators: Katharine J. Bar, University of Pennsylvania (Philadelphia, PA, USA), and Frank Kirchhoff, Ulm University Medical Center (Ulm, Germany)
- Cryoelectron Microscopy-Based Polyclonal Epitope Mapping (cryoEMPEM)
Gabriel Ozorowski, The Scripps Research Institute (La Jolla, CA, USA) - Correlative Light and Electron Microscopy (CLEM)
Barbara Müller, Heidelberg University (Heidelberg, Germany) - Tissue Imaging Technologies: Single-Virus Tracking
Kevin Welscher, Duke University (Durham, NC, USA) - Omics on Latently Infected T Cells
Iain Clark, University of California Berkeley (Berkeley, CA, USA)
Case-Based Workshop on the Liver and its Complications
Moderators: David L. Wyles, Denver Health Medical Center (Denver, CO, USA), and Annie Luetkemeyer, University of California San Francisco (San Francisco, CA, USA)
- Steatotic Liver Disease in Persons with HIV
Jennifer Price, University of California San Francisco (San Francisco, CA, USA) - Hepatitis Delta
Kathrin van Bremen, University of Bonn (Bonn, Germany) - Cirrhosis Management
Mazen Mpiko, University of Houston (Houston, TX, USA)
Case-Based Workshop on Antiretroviral Therapy: A Panel Discussion*
*new this year
Moderators and Case Presenters: Claudia P. Cortes, University of Chile (Santiago, Chile) and Rajesh T. Gandhi, Massachusetts General Hospital (Boston, MA, USA)
- Panel Discussion of Cases
Anchalee Avihingsanon, HIV-NAT (Bangkok, Thailand)
Cissy Kityo, Joint Clinical Research Centre (Kampala, Uganda)
Anton Pozniak, Chelsea and Westminster Hospital (London, UK)
Janine Trevillyan, Doherty Institute for Infection and Immunity (Melbourne, Australia)
Clinical Trial Design and Analysis
Moderators: Susan P. Buchbinder, San Francisco Department of Public Health (SanFrancisco, CA, USA), and Richard E. Chaisson, The Johns Hopkins University School of Medicine (Baltimore, MD, USA)
- Measuring User Preferences
José A. Bauermeister, University of Pennsylvania (Philadelphia, PA, USA) - Hybrid Effectiveness Implementation Studies
Elvin H. Geng, Washington University in St Louis (St Louis, MO, USA) - Stopping Trials Early
Sally Hunsberger, National Institute of Allergy and Infectious Diseases (Bethesda, MD, USA)
5:00 PM MT - 7:20 PM MT
Opening Session
Bernard Fields Lecture
Barney Graham, NIAID Vaccine Research Center (Bethesda, Maryland, USA)
The Bernard Fields Lecture recognizes a basic scientist for important and relevant contributions to the fields of virology and viral pathogenesis.
N’Galy-Mann Lecture
Dorothy M’bori-Ngacha, Formerly with United Nations Children’s Fund (Nairobi, Kenya)
The N’Galy-Mann Lecture recognizes an HIV/AIDS researcher for important and relevant work in the fields of epidemiology or clinical research.
Martin Delaney
Frank Mugisha, Sexual Minorities Uganda (SMUG) (Kampala, Uganda)
The Martin Delaney Presentation recognizes the important work of community advocacy and engagement in research.
8:30 AM MT - 9:30 AM MT
MONDAY PLENARY SESSION
What’s New in HIV Vaccines: Vaccine-Induced Immune Responses
Juliana M. McElrath, Fred Hutchinson Cancer Center (Seattle, WA, USA)
Shall We Reach HPV Elimination in the Face of Inequity?
Nelly Mugo, Kenya Medical Research Institute (Nairobi, Kenya)
10:00 AM MT - 12:00 PM MT
CONCURRENT ORAL ABSTRACT SESSIONS
Oral Abstract Sessions include leading-edge research in HIV, hepatitis viruses, SARS-CoV-2, and other viral infections and their related conditions. During these 2-hour sessions, speakers present their peer-reviewed research on a specific topic area and respond to questions from attendees in 1 of 2 question and answer periods moderated by experts in the field.
- HIV Immunology and Vaccines
- Neuropathogenesis of HIV
- Clinical Trials of Novel Antiretroviral Therapies
- Game Changers in Prevention of HIV and Sexually Transmitted Infections
12:00 PM MT - 1:30 PM MT
Lunch Break for Attendees and New Investigator Networking Sessions
1:30 PM MT - 2:30 PM MT
CONCURRENT THEMED DISCUSSIONS
Themed Discussions include up to 5 select poster abstracts connected by a theme. A discussant provides a 5-minute introduction outlining the state of the topic field, and then each presenter gives a brief overview of their Poster Abstract in 5 minutes using 5 slides (recommended) to summarize the noteworthy results, conclusions, and discussion points. Discussants interact with audience members and presenters to create a discussion that synthesizes the relevant information, covers key points of agreement and controversy, and draws comparisons to related work in the scientific field. At the conclusion of a Themed Discussion, the discussant provides a 5-minute summation highlighting the key information of the Poster Abstracts discussed and posing important questions for future research.
- Viral Rebound
- Is the Weight Over: GLP-1 Agonists Are Here
- PEP Prevention Toolbox: Do We Know How to Use It?
- Hazards Ahead: The Intersection of HIV and Substance Use
2:30 PM MT - 4:00 PM MT
POSTER SESSIONS
Poster Abstract Sessions comprise the majority of scientific information presented at CROI. Presenters of Poster Abstracts who attend CROI in person will be assigned to stand at their respective boards, organized by topic, on one of the 3 conference days. All posters will be available for viewing throughout the conference in the poster hall and in an electronic format on the CROI website and other electronic means (access is restricted to registered CROI attendees during the conference).
4:00 PM MT - 5:30 PM MT
CONCURRENT INTERACTIVE SESSIONS AND SYMPOSIA
The HIV Vaccine Journey: Don’t Stop Believin’
Moderators: Georgia D. Tomaras, Duke University (Durham, NC, USA), and Leonidas Stamatatos, Fred Hutchison Cancer Center (Seattle, WA, USA)
- Neutralizing Antibody Protection: Where Do We Go From Here?
Yunda Huang, Fred Hutchison Cancer Center (Seattle, WA, USA) - Germline Targeting Strategies to Get On the Road Again
Rogier W. Sanders, Academic Medical Center (Amsterdam, Netherlands)
- Novel Immunization Strategies to Move on Down the Road
Darrell Irvine, Massachusetts Institute of Technology (Cambridge, MA, USA)
Living Into Young Adulthood with Perinatal HIV
Moderator: Allison Agwu, Johns Hopkins University (Baltimore, MD, USA)
- Epidemiology of Perinatally Acquired HIV Among Adolescents and Young Adults
Mutsawashe Bwakura-Dangarembizi, University of Zimbabwe (Harare, Zimbabwe) - Social Determinants of Health Among Adolescents and Young Adults with Perinatal Acquire HIV
Ezer Kang, Howard University (Washington, DC, USA) - Cardiometabolic Risks and Complications: Adolescents and Young Adults with Perinatally Acquired HIV
Sahera Dirajlal-Fargo, Ann & Robert H Lurie Children’s Hospital of Chicago (Chicago, IL, USA)
The Return of Syphilis
Moderators: Jodie Dionne, University of Alabama at Birmingham (Birmingham, AL, USA), and Alex de Voux, University of Cape Town (Cape Town, South Africa)
- Why Can’t We Do Better at Diagnosing Syphilis?
Ina Park, University of California San Francisco (San Francisco, CA, USA) - The Burgeoning Epidemic of Congenital Syphilis
Angelica Espinosa Miranda, Ministry of Health (Brasilia, Brazil) - Management Conundrums
Khalil G. Ghanem, The Johns Hopkins University School of Medicine (Baltimore, MD, USA)
8:30 AM MT - 9:30 AM MT
TUESDAY PLENARY SESSION
Resistance, HIV Assembly, and Maturation Inhibitors
Eric Freed, National Institutes of Health (Bethesda, MD, USA)
Short-Course Prevention and Treatment of Tuberculosis
Vidya Mave, Byramjee Jeejeebhoy Government Medical College (Pune, India)
10:00 AM MT - 12:00 PM MT
CONCURRENT ORAL ABSTRACT SESSIONS
Oral Abstract Sessions include leading-edge research in HIV, hepatitis viruses, SARS-CoV-2, and other viral infections and their related conditions. During these 2-hour sessions, speakers present their peer-reviewed research on a specific topic area and respond to questions from attendees in 1 of 2 question and answer periods moderated by experts in the field.
- COVID-19: Epidemiologic and Clinical Insights
- Virus at the Wheel: Regulation of Replication and Immunity
- Combating Complications of HIV
- Hepatitis and Tuberculosis
- Leaning Into the Success of Biomedical HIV Prevention
12:00 PM MT - 1:30 PM MT
Lunch Break for Attendees and New Investigator Networking Sessions
1:30 PM MT - 2:30 PM MT
CONCURRENT THEMED DISCUSSIONS
Themed Discussions include up to 5 select poster abstracts connected by a theme. A discussant provides a 5-minute introduction outlining the state of the topic field, and then each presenter gives a brief overview of their Poster Abstract in 5 minutes using 5 slides (recommended) to summarize the noteworthy results, conclusions, and discussion points. Discussants interact with audience members and presenters to create a discussion that synthesizes the relevant information, covers key points of agreement and controversy, and draws comparisons to related work in the scientific field. At the conclusion of a Themed Discussion, the discussant provides a 5-minute summation highlighting the key information of the Poster Abstracts discussed and posing important questions for future research.
- Persistent Immune Activation and Inflammation During Antiretroviral Therapy
- Hypertension and HIV: Pregnancy, Postpartum, and Beyond
- Anal Cancer Screening and Pathogenesis
- Violence, Displacement, and HIV
2:30 PM MT - 4:00 PM MT
POSTER SESSIONS
Poster Abstract Sessions comprise the majority of scientific information presented at CROI. Presenters of Poster Abstracts who attend CROI in person will be assigned to stand at their respective boards, organized by topic, on one of the 3 conference days. All posters will be available for viewing throughout the conference in the poster hall and in an electronic format on the CROI website and other electronic means (access is restricted to registered CROI attendees during the conference).
4:00 PM MT - 5:30 PM MT
CONCURRENT INTERACTIVE SESSIONS AND SYMPOSIA
Not Just a Pretty Shape: HIV Assembly to Disassembly
Moderators: Owen Pornillos, University of Virginia (Charlottesville, VA, USA), and Melissa Kane, University of Pittsburgh (Pittsburgh, PA, USA)
- Virion Assembly: Selecting the Right RNA
Wei-Shau Hu, National Cancer Institute (Frederick, MD, USA) - Virion Maturation: Folding Into the Right Shape
Mamuka Kvaratskhelia, University of Colorado (Aurora, CO, USA) - Virion Disassembly: Keeping it Together Until the Right Moment
Gregory Towers, University College London (London, UK)
New Frontiers in Hepatitis B
Moderators: Gilles Wandeler, University of Bern (Bern, Switzerland), and Gail Matthews, Kirby Institute (Sydney, Australia)
- Hepatitis B in Sub-Saharan Africa
Olufunmilayo Lesi, World Health Organization (Geneva, Switzerland) - Novel Markers of Hepatitis B
Fabien Zoulim, L’Université Claude Bernard Lyon 1 (Lyon, France) - Immunologic Control of Hepatitis B
Adam Gehring, University of Toronto (Toronto, Canada)
Roundtable on DoxyPEP: Ready or Not…
Moderators: Kenneth Ngure, Kenya Medical Research Institute (Nairobi, Kenya) and Michael Traeger, Monash University (Melbourne, Australia)
- Introduction: Understanding the Issues
Chase Cannon, University of Washington (Seattle, WA, USA) - Should We Worry About Antimicrobial Resistance?
Béatrice Berçot, University Paris Cité (Paris, France) - Implementation Issues
Stephanie Cohen, San Francisco Department of Public Health (San Francisco, CA, USA)
Impact on HIV Care and Services Among Refugees, Displaced Persons, and Marginalized Populations
Moderators: Wafaa El-Sadr, Columbia University (New York, NY, USA) and Carlos del Rio, Emory University (Atlanta, GA, USA)
- Overview of the Global Displacement Crisis
Mesfin T. Tessema, International Rescue Committee (New York, NY, USA) - Meeting the Needs of People Affected by HIV From Ukraine
Milosz Parczewski, Pomeranian Medical University (Szczecin, Poland) - Protracted Consequences of Displacement: A Perspective from the Syrian Crisis
Fouad M. Fouad, American University of Beirut (Beirut, Lebanon) - Lived Experience from Ukraine
Yana Panfilova, Teenergizer (Kyiv, Ukraine)
8:30 AM MT - 9:30 AM MT
WEDNESDAY PLENARY SESSION
The End of Oral? How Long-Acting Formulations Are Changing the Management of Infectious Diseases
Charles Flexner, The John Hopkins University (Baltimore, MD, USA)
New Frontiers in Testing: Technologies and Programs
Nitika Pai, McGill University (Montreal, Quebec, Canada)
10:00 AM MT - 12:00 PM MT
CONCURRENT ORAL ABSTRACT SESSIONS
Oral Abstract Sessions include leading-edge research in HIV, hepatitis viruses, SARS-CoV-2, and other viral infections and their related conditions. During these 2-hour sessions, speakers present their peer-reviewed research on a specific topic area and respond to questions from attendees in 1 of 2 question and answer periods moderated by experts in the field.
- HIV Reservoir and Cure Strategies
- HIV Across the Life Continuum: Pregnant People, Infants, Children, and Adolescents
- HIV Epidemiology: Using Data to Inform Future Interventions
- Interventions to Improve HIV Testing and Treatment
12:00 PM MT - 1:30 PM MT
Lunch Break for Attendees and New Investigator Networking Sessions
1:30 PM MT - 2:30 PM MT
CONCURRENT THEMED DISCUSSIONS
Themed Discussions include up to 5 select poster abstracts connected by a theme. A discussant provides a 5-minute introduction outlining the state of the topic field, and then each presenter gives a brief overview of their Poster Abstract in 5 minutes using 5 slides (recommended) to summarize the noteworthy results, conclusions, and discussion points. Discussants interact with audience members and presenters to create a discussion that synthesizes the relevant information, covers key points of agreement and controversy, and draws comparisons to related work in the scientific field. At the conclusion of a Themed Discussion, the discussant provides a 5-minute summation highlighting the key information of the Poster Abstracts discussed and posing important questions for future research.
- Mucosal Immunity to HIV
- Strategies for an HIV Cure
- Dolutegravir Resistance in Resource-Limited Settings
- Novel Interventions in HIV Programming
2:30 PM MT - 4:00 PM MT
POSTER SESSIONS
Poster Abstract Sessions comprise the majority of scientific information presented at CROI. Presenters of Poster Abstracts who attend CROI in person will be assigned to stand at their respective boards, organized by topic, on one of the 3 conference days. All posters will be available for viewing throughout the conference in the poster hall and in an electronic format on the CROI website and other electronic means (access is restricted to registered CROI attendees during the conference).
4:00 PM MT - 5:30 PM MT
CONCURRENT INTERACTIVE SESSIONS AND SYMPOSIA
Innovations in Intervention: Toward an HIV Cure
Moderator: Marina Lusic, Heidelberg University (Heidelberg, Germany) and Maria Buzón, Vall d’Hebron Research Institute (Barcelona, Spain)
- From Mechanisms to Therapeutics: Eliminating Infected Cells by Inflammasome Activation
Liang Shan, Washington University in St Louis (St Louis, MO, USA) - From Therapeutics to Mechanisms: NNRTI Kills HIV-Infected Cells Through Inflammasome Activation
Tracy L Diamond, Merck & Co, Inc (West Point, PA, USA) - From Transcriptomics to Therapeutics: A Host Restriction Factor That Targets HIV Expression
Rasmi Thomas, Walter Reed Army Institute of Research (Silver Spring, MD,USA) - From Structure to Therapeutics: CD4 Mimetics Opens Env Conformation and Increases ADCC
Andrés Finzi, Université de Montréal (Montreal, Canada)
Follow Your Heart: Managing Cardiovascular Disease Risk in PWH
Moderators: Matthew J Feinstein, Northwestern University (Chicago, IL, USA), and Franck Boccara (Sorbonne Universite, Paris, France)
- REPRIEVE Trial Overview: Mechanism Underlying Sex Differences in Assessing Risk of CVD
Markella Zanni, Massachusetts General Hospital (Boston, MA, USA) - What’s Next: Immune-Based Therapy for CVD and Comparison With the General Population
Priscilla Y. Hsue, University of California San Francisco (San Francisco, CA, USA) - Implications for Implementing CVD Risk Prevention Strategies for LMIC
Mpiko Ntsekhe, University of Cape Town (Cape Town, South Africa)
Promise and Pitfalls of Biomedical Prevention: Beyond Phase III
Moderators: Linda-Gail Bekker, Desmond Tutu HIV Foundation (Cape Town, South Africa), and Bruno Spire, Institut National de la Santé et de la Recherche Médicale (Marseille, France)
- Why is Cabotegravir Rollout So Slow?
Rupa Patel, Centers for Disease Control and Prevention (Atlanta, GA, USA) - The Ring Comes Full Circle
Leila E. Mansoor, Centre for the AIDS Programme of Research in South Africa (Durban, South Africa) - Challenging the Dogma of Event-Driven PrEP
Jenell Stewart, Hennepin Healthcare Research Institute (Minneapolis, MN, USA)
- Sunday, March 3, 2024
-
8:30 AM MT - 12:30 PM MT
New Investigator Workshop
Scott M. Hammer Workshop for New Investigators and Trainees
Widely considered the most informative and comprehensive session, this workshop highlights key presentations that will take place during CROI. Although the workshop is directed toward new investigators and trainees (eg, undergraduate students, graduate students, postdoctoral fellows, and physician fellows), all CROI attendees are encouraged to attend. Scholarship recipients are required to attend.
Moderators: Katharine J. Bar, Hospital of the University of Pennsylvania (Philadelphia, PA, USA), and Serena S. Spudich, Yale University (New Haven, CT, USA)
-
- Community Perspective on CROI 2024
Adam Castillejo, London Patient (London, United Kingdom) - Navigating Presentations in Molecular Virology at CROI 2024
Frank Kirchhoff, Ulm University Medical Center (Ulm, Germany) - Navigating Presentations in SARS-CoV-2 and HIV Immunology
Elizabeth Connick, University of Arizona (Tucson, AZ, USA) - Navigating Presentations in HIV Cure at CROI 2024
Afam A. Okoye, Oregon Health and Sciences University (Portland, OR, USA) - Navigating Presentations in Prevention at CROI 2024
LaRon Nelson, Yale University (New Haven, CT, USA) - Navigating Presentations in Pediatric HIV at CROI 2024
Jennifer Jao, Northwestern University (Chicago, IL, USA) - Special Presentation by the Director of the NIAID
Jeanne Marrazzo, National Institute of Allergy and Infectious Diseases (Bethesda, MD, USA)
- Community Perspective on CROI 2024
2:00 PM PT - 4:00 PM MT
CONCURRENT TECHNICAL WORKSHOPS
Frontiers in Laboratory Technologies
Moderators: Katharine J. Bar, University of Pennsylvania (Philadelphia, PA, USA), and Frank Kirchhoff, Ulm University Medical Center (Ulm, Germany)
- Cryoelectron Microscopy-Based Polyclonal Epitope Mapping (cryoEMPEM)
Gabriel Ozorowski, The Scripps Research Institute (La Jolla, CA, USA) - Correlative Light and Electron Microscopy (CLEM)
Barbara Müller, Heidelberg University (Heidelberg, Germany) - Tissue Imaging Technologies: Single-Virus Tracking
Kevin Welscher, Duke University (Durham, NC, USA) - Omics on Latently Infected T Cells
Iain Clark, University of California Berkeley (Berkeley, CA, USA)
Case-Based Workshop on the Liver and its Complications
Moderators: David L. Wyles, Denver Health Medical Center (Denver, CO, USA), and Annie Luetkemeyer, University of California San Francisco (San Francisco, CA, USA)
- Steatotic Liver Disease in Persons with HIV
Jennifer Price, University of California San Francisco (San Francisco, CA, USA) - Hepatitis Delta
Kathrin van Bremen, University of Bonn (Bonn, Germany) - Cirrhosis Management
Mazen Mpiko, University of Houston (Houston, TX, USA)
Case-Based Workshop on Antiretroviral Therapy: A Panel Discussion*
*new this yearModerators and Case Presenters: Claudia P. Cortes, University of Chile (Santiago, Chile) and Rajesh T. Gandhi, Massachusetts General Hospital (Boston, MA, USA)
- Panel Discussion of Cases
Anchalee Avihingsanon, HIV-NAT (Bangkok, Thailand)
Cissy Kityo, Joint Clinical Research Centre (Kampala, Uganda)
Anton Pozniak, Chelsea and Westminster Hospital (London, UK)
Janine Trevillyan, Doherty Institute for Infection and Immunity (Melbourne, Australia)
Clinical Trial Design and Analysis
Moderators: Susan P. Buchbinder, San Francisco Department of Public Health (SanFrancisco, CA, USA), and Richard E. Chaisson, The Johns Hopkins University School of Medicine (Baltimore, MD, USA)
- Measuring User Preferences
José A. Bauermeister, University of Pennsylvania (Philadelphia, PA, USA) - Hybrid Effectiveness Implementation Studies
Elvin H. Geng, Washington University in St Louis (St Louis, MO, USA) - Stopping Trials Early
Sally Hunsberger, National Institute of Allergy and Infectious Diseases (Bethesda, MD, USA)
5:00 PM MT - 7:20 PM MT
Opening Session
Bernard Fields Lecture
Barney Graham, NIAID Vaccine Research Center (Bethesda, Maryland, USA)
The Bernard Fields Lecture recognizes a basic scientist for important and relevant contributions to the fields of virology and viral pathogenesis.
N’Galy-Mann Lecture
Dorothy M’bori-Ngacha, Formerly with United Nations Children’s Fund (Nairobi, Kenya)
The N’Galy-Mann Lecture recognizes an HIV/AIDS researcher for important and relevant work in the fields of epidemiology or clinical research.
Martin Delaney
Frank Mugisha, Sexual Minorities Uganda (SMUG) (Kampala, Uganda)
The Martin Delaney Presentation recognizes the important work of community advocacy and engagement in research.
-
- Monday, March 4, 2024
-
8:30 AM MT - 9:30 AM MT
MONDAY PLENARY SESSION
What’s New in HIV Vaccines: Vaccine-Induced Immune Responses
Juliana M. McElrath, Fred Hutchinson Cancer Center (Seattle, WA, USA)Shall We Reach HPV Elimination in the Face of Inequity?
Nelly Mugo, Kenya Medical Research Institute (Nairobi, Kenya)10:00 AM MT - 12:00 PM MT
CONCURRENT ORAL ABSTRACT SESSIONS
Oral Abstract Sessions include leading-edge research in HIV, hepatitis viruses, SARS-CoV-2, and other viral infections and their related conditions. During these 2-hour sessions, speakers present their peer-reviewed research on a specific topic area and respond to questions from attendees in 1 of 2 question and answer periods moderated by experts in the field.
- HIV Immunology and Vaccines
- Neuropathogenesis of HIV
- Clinical Trials of Novel Antiretroviral Therapies
- Game Changers in Prevention of HIV and Sexually Transmitted Infections
12:00 PM MT - 1:30 PM MT
Lunch Break for Attendees and New Investigator Networking Sessions
1:30 PM MT - 2:30 PM MT
CONCURRENT THEMED DISCUSSIONS
Themed Discussions include up to 5 select poster abstracts connected by a theme. A discussant provides a 5-minute introduction outlining the state of the topic field, and then each presenter gives a brief overview of their Poster Abstract in 5 minutes using 5 slides (recommended) to summarize the noteworthy results, conclusions, and discussion points. Discussants interact with audience members and presenters to create a discussion that synthesizes the relevant information, covers key points of agreement and controversy, and draws comparisons to related work in the scientific field. At the conclusion of a Themed Discussion, the discussant provides a 5-minute summation highlighting the key information of the Poster Abstracts discussed and posing important questions for future research.
- Viral Rebound
- Is the Weight Over: GLP-1 Agonists Are Here
- PEP Prevention Toolbox: Do We Know How to Use It?
- Hazards Ahead: The Intersection of HIV and Substance Use
2:30 PM MT - 4:00 PM MT
POSTER SESSIONS
Poster Abstract Sessions comprise the majority of scientific information presented at CROI. Presenters of Poster Abstracts who attend CROI in person will be assigned to stand at their respective boards, organized by topic, on one of the 3 conference days. All posters will be available for viewing throughout the conference in the poster hall and in an electronic format on the CROI website and other electronic means (access is restricted to registered CROI attendees during the conference).
4:00 PM MT - 5:30 PM MT
CONCURRENT INTERACTIVE SESSIONS AND SYMPOSIA
The HIV Vaccine Journey: Don’t Stop Believin’
Moderators: Georgia D. Tomaras, Duke University (Durham, NC, USA), and Leonidas Stamatatos, Fred Hutchison Cancer Center (Seattle, WA, USA)
- Neutralizing Antibody Protection: Where Do We Go From Here?
Yunda Huang, Fred Hutchison Cancer Center (Seattle, WA, USA) - Germline Targeting Strategies to Get On the Road Again
Rogier W. Sanders, Academic Medical Center (Amsterdam, Netherlands)
- Novel Immunization Strategies to Move on Down the Road
Darrell Irvine, Massachusetts Institute of Technology (Cambridge, MA, USA)
Living Into Young Adulthood with Perinatal HIV
Moderator: Allison Agwu, Johns Hopkins University (Baltimore, MD, USA)
- Epidemiology of Perinatally Acquired HIV Among Adolescents and Young Adults
Mutsawashe Bwakura-Dangarembizi, University of Zimbabwe (Harare, Zimbabwe) - Social Determinants of Health Among Adolescents and Young Adults with Perinatal Acquire HIV
Ezer Kang, Howard University (Washington, DC, USA) - Cardiometabolic Risks and Complications: Adolescents and Young Adults with Perinatally Acquired HIV
Sahera Dirajlal-Fargo, Ann & Robert H Lurie Children’s Hospital of Chicago (Chicago, IL, USA)
The Return of Syphilis
Moderators: Jodie Dionne, University of Alabama at Birmingham (Birmingham, AL, USA), and Alex de Voux, University of Cape Town (Cape Town, South Africa)
- Why Can’t We Do Better at Diagnosing Syphilis?
Ina Park, University of California San Francisco (San Francisco, CA, USA) - The Burgeoning Epidemic of Congenital Syphilis
Angelica Espinosa Miranda, Ministry of Health (Brasilia, Brazil) - Management Conundrums
Khalil G. Ghanem, The Johns Hopkins University School of Medicine (Baltimore, MD, USA)
- Tuesday, March 5, 2024
-
8:30 AM MT - 9:30 AM MT
TUESDAY PLENARY SESSION
Resistance, HIV Assembly, and Maturation Inhibitors
Eric Freed, National Institutes of Health (Bethesda, MD, USA)Short-Course Prevention and Treatment of Tuberculosis
Vidya Mave, Byramjee Jeejeebhoy Government Medical College (Pune, India)10:00 AM MT - 12:00 PM MT
CONCURRENT ORAL ABSTRACT SESSIONS
Oral Abstract Sessions include leading-edge research in HIV, hepatitis viruses, SARS-CoV-2, and other viral infections and their related conditions. During these 2-hour sessions, speakers present their peer-reviewed research on a specific topic area and respond to questions from attendees in 1 of 2 question and answer periods moderated by experts in the field.
- COVID-19: Epidemiologic and Clinical Insights
- Virus at the Wheel: Regulation of Replication and Immunity
- Combating Complications of HIV
- Hepatitis and Tuberculosis
- Leaning Into the Success of Biomedical HIV Prevention
12:00 PM MT - 1:30 PM MT
Lunch Break for Attendees and New Investigator Networking Sessions
1:30 PM MT - 2:30 PM MT
CONCURRENT THEMED DISCUSSIONS
Themed Discussions include up to 5 select poster abstracts connected by a theme. A discussant provides a 5-minute introduction outlining the state of the topic field, and then each presenter gives a brief overview of their Poster Abstract in 5 minutes using 5 slides (recommended) to summarize the noteworthy results, conclusions, and discussion points. Discussants interact with audience members and presenters to create a discussion that synthesizes the relevant information, covers key points of agreement and controversy, and draws comparisons to related work in the scientific field. At the conclusion of a Themed Discussion, the discussant provides a 5-minute summation highlighting the key information of the Poster Abstracts discussed and posing important questions for future research.
- Persistent Immune Activation and Inflammation During Antiretroviral Therapy
- Hypertension and HIV: Pregnancy, Postpartum, and Beyond
- Anal Cancer Screening and Pathogenesis
- Violence, Displacement, and HIV
2:30 PM MT - 4:00 PM MT
POSTER SESSIONS
Poster Abstract Sessions comprise the majority of scientific information presented at CROI. Presenters of Poster Abstracts who attend CROI in person will be assigned to stand at their respective boards, organized by topic, on one of the 3 conference days. All posters will be available for viewing throughout the conference in the poster hall and in an electronic format on the CROI website and other electronic means (access is restricted to registered CROI attendees during the conference).
4:00 PM MT - 5:30 PM MT
CONCURRENT INTERACTIVE SESSIONS AND SYMPOSIA
Not Just a Pretty Shape: HIV Assembly to Disassembly
Moderators: Owen Pornillos, University of Virginia (Charlottesville, VA, USA), and Melissa Kane, University of Pittsburgh (Pittsburgh, PA, USA)
- Virion Assembly: Selecting the Right RNA
Wei-Shau Hu, National Cancer Institute (Frederick, MD, USA) - Virion Maturation: Folding Into the Right Shape
Mamuka Kvaratskhelia, University of Colorado (Aurora, CO, USA) - Virion Disassembly: Keeping it Together Until the Right Moment
Gregory Towers, University College London (London, UK)
New Frontiers in Hepatitis B
Moderators: Gilles Wandeler, University of Bern (Bern, Switzerland), and Gail Matthews, Kirby Institute (Sydney, Australia)
- Hepatitis B in Sub-Saharan Africa
Olufunmilayo Lesi, World Health Organization (Geneva, Switzerland) - Novel Markers of Hepatitis B
Fabien Zoulim, L’Université Claude Bernard Lyon 1 (Lyon, France) - Immunologic Control of Hepatitis B
Adam Gehring, University of Toronto (Toronto, Canada)
Roundtable on DoxyPEP: Ready or Not…
Moderators: Kenneth Ngure, Kenya Medical Research Institute (Nairobi, Kenya) and Michael Traeger, Monash University (Melbourne, Australia)
- Introduction: Understanding the Issues
Chase Cannon, University of Washington (Seattle, WA, USA) - Should We Worry About Antimicrobial Resistance?
Béatrice Berçot, University Paris Cité (Paris, France) - Implementation Issues
Stephanie Cohen, San Francisco Department of Public Health (San Francisco, CA, USA)
Impact on HIV Care and Services Among Refugees, Displaced Persons, and Marginalized Populations
Moderators: Wafaa El-Sadr, Columbia University (New York, NY, USA) and Carlos del Rio, Emory University (Atlanta, GA, USA)
- Overview of the Global Displacement Crisis
Mesfin T. Tessema, International Rescue Committee (New York, NY, USA) - Meeting the Needs of People Affected by HIV From Ukraine
Milosz Parczewski, Pomeranian Medical University (Szczecin, Poland) - Protracted Consequences of Displacement: A Perspective from the Syrian Crisis
Fouad M. Fouad, American University of Beirut (Beirut, Lebanon) - Lived Experience from Ukraine
Yana Panfilova, Teenergizer (Kyiv, Ukraine)
- Wednesday, March 6, 2024
-
8:30 AM MT - 9:30 AM MT
WEDNESDAY PLENARY SESSION
The End of Oral? How Long-Acting Formulations Are Changing the Management of Infectious Diseases
Charles Flexner, The John Hopkins University (Baltimore, MD, USA)New Frontiers in Testing: Technologies and Programs
Nitika Pai, McGill University (Montreal, Quebec, Canada)10:00 AM MT - 12:00 PM MT
CONCURRENT ORAL ABSTRACT SESSIONS
Oral Abstract Sessions include leading-edge research in HIV, hepatitis viruses, SARS-CoV-2, and other viral infections and their related conditions. During these 2-hour sessions, speakers present their peer-reviewed research on a specific topic area and respond to questions from attendees in 1 of 2 question and answer periods moderated by experts in the field.
- HIV Reservoir and Cure Strategies
- HIV Across the Life Continuum: Pregnant People, Infants, Children, and Adolescents
- HIV Epidemiology: Using Data to Inform Future Interventions
- Interventions to Improve HIV Testing and Treatment
12:00 PM MT - 1:30 PM MT
Lunch Break for Attendees and New Investigator Networking Sessions
1:30 PM MT - 2:30 PM MT
CONCURRENT THEMED DISCUSSIONS
Themed Discussions include up to 5 select poster abstracts connected by a theme. A discussant provides a 5-minute introduction outlining the state of the topic field, and then each presenter gives a brief overview of their Poster Abstract in 5 minutes using 5 slides (recommended) to summarize the noteworthy results, conclusions, and discussion points. Discussants interact with audience members and presenters to create a discussion that synthesizes the relevant information, covers key points of agreement and controversy, and draws comparisons to related work in the scientific field. At the conclusion of a Themed Discussion, the discussant provides a 5-minute summation highlighting the key information of the Poster Abstracts discussed and posing important questions for future research.
- Mucosal Immunity to HIV
- Strategies for an HIV Cure
- Dolutegravir Resistance in Resource-Limited Settings
- Novel Interventions in HIV Programming
2:30 PM MT - 4:00 PM MT
POSTER SESSIONS
Poster Abstract Sessions comprise the majority of scientific information presented at CROI. Presenters of Poster Abstracts who attend CROI in person will be assigned to stand at their respective boards, organized by topic, on one of the 3 conference days. All posters will be available for viewing throughout the conference in the poster hall and in an electronic format on the CROI website and other electronic means (access is restricted to registered CROI attendees during the conference).
4:00 PM MT - 5:30 PM MT
CONCURRENT INTERACTIVE SESSIONS AND SYMPOSIA
Innovations in Intervention: Toward an HIV Cure
Moderator: Marina Lusic, Heidelberg University (Heidelberg, Germany) and Maria Buzón, Vall d’Hebron Research Institute (Barcelona, Spain)
- From Mechanisms to Therapeutics: Eliminating Infected Cells by Inflammasome Activation
Liang Shan, Washington University in St Louis (St Louis, MO, USA) - From Therapeutics to Mechanisms: NNRTI Kills HIV-Infected Cells Through Inflammasome Activation
Tracy L Diamond, Merck & Co, Inc (West Point, PA, USA) - From Transcriptomics to Therapeutics: A Host Restriction Factor That Targets HIV Expression
Rasmi Thomas, Walter Reed Army Institute of Research (Silver Spring, MD,USA) - From Structure to Therapeutics: CD4 Mimetics Opens Env Conformation and Increases ADCC
Andrés Finzi, Université de Montréal (Montreal, Canada)
Follow Your Heart: Managing Cardiovascular Disease Risk in PWH
Moderators: Matthew J Feinstein, Northwestern University (Chicago, IL, USA), and Franck Boccara (Sorbonne Universite, Paris, France)
- REPRIEVE Trial Overview: Mechanism Underlying Sex Differences in Assessing Risk of CVD
Markella Zanni, Massachusetts General Hospital (Boston, MA, USA) - What’s Next: Immune-Based Therapy for CVD and Comparison With the General Population
Priscilla Y. Hsue, University of California San Francisco (San Francisco, CA, USA) - Implications for Implementing CVD Risk Prevention Strategies for LMIC
Mpiko Ntsekhe, University of Cape Town (Cape Town, South Africa)
Promise and Pitfalls of Biomedical Prevention: Beyond Phase III
Moderators: Linda-Gail Bekker, Desmond Tutu HIV Foundation (Cape Town, South Africa), and Bruno Spire, Institut National de la Santé et de la Recherche Médicale (Marseille, France)
- Why is Cabotegravir Rollout So Slow?
Rupa Patel, Centers for Disease Control and Prevention (Atlanta, GA, USA) - The Ring Comes Full Circle
Leila E. Mansoor, Centre for the AIDS Programme of Research in South Africa (Durban, South Africa) - Challenging the Dogma of Event-Driven PrEP
Jenell Stewart, Hennepin Healthcare Research Institute (Minneapolis, MN, USA)
Last Modified: